financetom
Business
financetom
/
Business
/
State Street's Asset Management Arm Makes Minority Investment in Coller Capital
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
State Street's Asset Management Arm Makes Minority Investment in Coller Capital
Nov 3, 2025 7:00 AM

09:38 AM EST, 11/03/2025 (MT Newswires) -- State Street's (STT) asset management arm, State Street Investment Management, said Monday that it has made a strategic minority investment in Coller Capital, a private market secondaries manager.

The investment will support Coller's long-term growth strategy, while also expanding State Street Investment Management's reach into the secondaries markets, the statement added.

Financial details of the investment were not disclosed.

Price: 115.14, Change: -0.55, Percent Change: -0.47

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Form 8.3 - Spectris PLC
Form 8.3 - Spectris PLC
Nov 3, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
BioCryst Pharmaceuticals' Q3 Non-GAAP Earnings, Revenue Increase
BioCryst Pharmaceuticals' Q3 Non-GAAP Earnings, Revenue Increase
Nov 3, 2025
07:18 AM EST, 11/03/2025 (MT Newswires) -- BioCryst Pharmaceuticals ( BCRX ) reported Q3 non-GAAP earnings Monday of $0.16 per diluted share, up from $0.02 a year earlier. Analysts polled by FactSet expected $0.07. Revenue for the quarter ended Sept. 30 was $159.4 million, up from $117.1 million a year earlier. Analysts polled by FactSet expected $$163 million. The company...
TG Therapeutics Q3 Net Income, Revenue Rise; Raises 2025 Revenue Guidance
TG Therapeutics Q3 Net Income, Revenue Rise; Raises 2025 Revenue Guidance
Nov 3, 2025
07:20 AM EST, 11/03/2025 (MT Newswires) -- TG Therapeutics ( TGTX ) reported Q3 net income Monday of $2.43 per diluted share, up from $0.02 a year earlier. Analysts polled by FactSet expected $0.22. Revenue for the quarter ended Sept. 30 was $161.7 million, compared with $83.9 million a year earlier. Analysts surveyed by FactSet expected $152.1 million. For 2025,...
KBR's Brown & Root Industrial Services JV to Acquire Specialty Welding and Turnarounds
KBR's Brown & Root Industrial Services JV to Acquire Specialty Welding and Turnarounds
Nov 3, 2025
07:19 AM EST, 11/03/2025 (MT Newswires) -- KBR (KBR) said Monday its Brown & Root Industrial Services joint venture has signed a deal to acquire Specialty Welding and Turnarounds. Financial terms were not disclosed. Louisiana-based Specialty Welding offers turnaround, cooling tower, and industrial catalyst services, the company said. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved